Article Abstract

Extending the curve: survival of EGFR-mutated lung cancer patients in the 21st century

Authors: Feliciano Barrón, Zyanya Lucia Zatarain-Barrón, Andrés F. Cardona, Oscar Arrieta


Lung cancer remains the most lethal malignancy worldwide (1,2). Although incidence rates have decreased in part of the developed world, other regions face the challenge of an epidemic of paramount importance, which is likely to take hundreds of thousands of lives in the coming years (2,3).